🇺🇸 FDA
Patent

US 9056068

Vaccine and methods of use against Strongyloide stercoralis infection

granted A61KA61K39/0003A61P

Quick answer

US patent 9056068 (Vaccine and methods of use against Strongyloide stercoralis infection) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K39/0003, A61P, A61P33/00